SCHEMBL8974760

SCHEMBL8974760

CC(COc1ccc(CC2SC(=O)NC2=O)cc1)N1CC(COCCCc2ccccc2)OC1=O

nearest known ligand 0.46

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 11/20 0.46
HRH3 Q9Y5N1 1/20 0.44
PPARG P37231 9/20 0.43
PPARA Q07869 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8975293 0.98 FFAR1 (0.45) FFAR1HRH3PPARGPPARA
SCHEMBL8974612 0.97 FFAR1 (0.45) FFAR1HRH3PPARGPPARA
SCHEMBL8974991 0.97 FFAR1 (0.45) FFAR1HRH3PPARGPPARA
SCHEMBL8975410 0.97 FFAR1 (0.45) FFAR1HRH3PPARGPPARA
SCHEMBL8975162 0.97 FFAR1 (0.45) FFAR1HRH3PPARGPPARA
SCHEMBL8975053 0.95 FFAR1 (0.47) FFAR1HRH3PPARGPPARA
SCHEMBL8975065 0.91 FFAR1 (0.48) FFAR1PPARGPPARA
SCHEMBL8974634 0.89 FFAR1 (0.49) FFAR1HRH3PPARGPPARA
SCHEMBL8975414 0.89 FFAR1 (0.51) FFAR1PPARGPPARA
SCHEMBL8975066 0.86 FFAR1 (0.51) FFAR1PPARGPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5578620-A TREATMENT OF DIABETES AND HYPERLIPEMIA SANKYO COMPANY, LIMITED (JP) 1996-11-26 US disclosed